Enliven Therapeutics, Inc. (ELVN)
38.83
+1.04
(+2.75%)
USD |
NASDAQ |
Apr 02, 16:00
38.72
-0.11
(-0.28%)
After-Hours: 20:00
Enliven Therapeutics Shareholders Equity (Quarterly) : 459.60M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Sarepta Therapeutics, Inc. | 1.141B |
| Coherus Oncology, Inc. | 61.01M |
| Kodiak Sciences, Inc. | 157.38M |
| Allogene Therapeutics, Inc. | 292.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 476.28M |
| Total Liabilities (Quarterly) | 16.68M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 28.66 |
| Net Debt Paydown Yield | -0.01% |